Osvaldo Bazil-Mieses
Internal Medicine · Mayaguez, PRNPI 1174523732
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 77 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 16.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $638 and has fallen 89.2% since, to $69 in 2023.
Across 77 payments — averaging $19.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$243
- Lilly USA, LLC$197
- Mayne Pharma Commercial LLC$184
- Hologic Sales And Service, LLC$119
- Amarin Pharma, Inc.$114
- Boehringer Ingelheim$105
- plus $507 from 14 others
What the payments were for
- Food & beverage$1,469100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 18 | $243 |
| Lilly USA, LLC | 12 | $197 |
| Mayne Pharma Commercial LLC | 1 | $184 |
| Hologic Sales And Service, LLC | 2 | $119 |
| Amarin Pharma, Inc. | 7 | $114 |
| Boehringer Ingelheim | 5 | $105 |
| Johnson & Johnson | 6 | $100 |
| AbbVie | 5 | $82 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $57 |
| Pfizer | 3 | $53 |
| Philips North America LLC | 2 | $38 |
| Sanofi-aventis U.S. LLC | 2 | $30 |
| GSK | 2 | $29 |
| Amgen(2 entities) | 2 | $28 |
| Novartis | 1 | $20 |
| Scilex Pharmaceuticals Inc. | 1 | $18 |
| Radius Health, Inc. | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| AstraZeneca | 1 | $12 |
How this compares
$1,469 in reported general payments places this provider in the 70th percentile of 1,043 internal medicine providers in Puerto Rico.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 16 | $197 |
| Gabapentin | 13 | $186 |
| Azithromycin | 13 | $116 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Mayaguez
- Javier TorresMayaguez$10K
- Nelson VallejoLas Piedras$621K
- Ricardo FernandezSan Juan$351K
- Ronald Collazo PaganManati$206K
- Angel VinuelaDorado$182K
- Julio JimenezSan Lorenzo$99K
- Luis Negron GarciaSan German$24K
- Jorge Torres OlmedaCoto Laurel$23K
- Norma SalgadoSan Juan$21K
- Victor Gordo GonzalezSan Juan$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.